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Introduction
Complex mixtures of mycolic acids are characteristic components of mycobacterial cells, either bound to the wall as arabinose esters or not bound to the wall, as free acids or esterified to sugars such as glucose (GMM), or trehalose (dimycolate, TDM; monomycolate, TMM) [1] . As early as 1956, it was shown that Mycobacterium tuberculosis contains mycoloylglycerols (ca. 90 carbons) [2 -5] . Glycerol monomycolate (GroMM, also known as MMG) is also present in the wax C fraction of BCG [6] . Shorter chain glycerol esters were isolated from Nocardia rhodochrous, which contains nocardomycoloylglycerols (40 -44 carbons) [7] , from Corynebacterium pseudotuberculosis (30 -36 carbons) [8] , from Nocardia asteroides (50 -56 carbons) [9] , and from Rhodococcus lentifragmentus (32 -50 carbons) [10] .
The glycerol is esterified at one of the primary alcohol groups [11] . The antigen isolated from Mycobacterium bovis BCG was shown to exist as two stereoisomers at the glycerol by comparison of the NMR spectrum with those of R-and S-glycerol isomers of GroMM prepared from mycolic acid mixtures isolated from M.tuberculosis H37Rv cells [12] . Both semi-synthetic GroMMs stimulate CD-1 restricted T cell clones, the R-isomer being more slightly more stimulatory than GroMM from Mycobacterium bovis BCG, the S-isomer slightly less stimulatory. In this system, R and S-isomers of GroMM prepared from a 32 carbon corynomycolate almost completely removed the stimulatory effect, in line with earlier results [13] . The secondary alcohol group of the glycerol was also necessary for activity. GroMM was presented by M. tuberculosis infected dendritic cells, demonstrating that the antigen is available for presentation during natural infection. Ex vivo experiments showed that GroMM stimulated T cells from vaccinated or latently infected healthy donors but not those from patients with active tuberculosis, suggesting that GroMM-specific T cells are primed during infection and their detection correlates with lack of clinically active disease [12] . Hattori et al. immunized guinea pigs with bacillus Calmette-Guérin (BCG) expressing high levels of GroMM and then monitored skin reactions at the site of inoculation with GroMM-containing liposome. The host responses to GroMM produced by dormant mycobacteria contribute to their long-term survival in the host [14] , again identifying GroMM M A N U C R I P T A C C E P T E D ACCEPTED MANUSCRIPT • 2 as potentially associated with latent infection. GroMM is a ligand for the human, but not mouse macrophage inducible c-type lectin, Mincle [15] , the signalling process being dependent on structure [16, 17] .
A 32 carbon monomycolyl GroMM analogue demonstrated enhanced immunostimulatory activity in a dioctadecyl ammonium bromide/Ag85B-ESAT-6 formulation. Elevated levels of IFN-gamma and IL-6 were produced in spleen cells from mice immunised with a 32 carbon GroMM analogue comparable activity to the potent Th1 adjuvant, trehalose 6,6'-dibehenate [18 -22] . Interest in the properties and applications of GroMMs therefore remains high [23 -26] .
Derivatives of GroMMs in which the two other glycerol alcohol groups are acylated have also been reported [27] .
Layre et al. prepared GroMM using potassium salts of mixtures of mycolates isolated from M. tuberculosis H37Rv [12] , using (S)-and (R)-isopropylidene-glycerol p-toluenesulfonates 1 and 2 (Scheme 1).
Scheme 1: The synthesis of GroMM with natural mycolic acid [13]
Nordly et al. synthesised GroMMs from unfunctionalised C 32 β-hydroxy acids producing a mixture of four stereoisomers, and carried out extensive studies of their bioactivity [21] .
In order to determine whether the detailed structure of the individual mycolic acid in the natural mixtures leads to changes in their biological properties, or whether the activity is dominated by the glycerol fragment, we now report the synthesis of GroMMs based on coupling of a set of individual complete synthetic mycolic acids, taken from various Mtb classes, with both glycerol stereoisomers. .
Results and discussion
The synthetic mycolic esters of R-glycerol 10 were prepared by two methods. In the first, the TBDMS protected MA was coupled with acetonide 8 promoted by DCC and DMAP. In the M A N U C R I P T
A C C E P T E D ACCEPTED MANUSCRIPT The S-glycerol mycolate esters were prepared by a modified method in which the glycerol was protected by benzyl groups, which, after coupling, were removed by hydrogenolysis: 
Conclusion
A set of nine R-and S-glycerol mycolates derived from single synthetic α-, keto-and methoxy-mycolic acids are described. The GroMMs 10a -10d did not show any significant effects in the stimulation of cytokines in bone marrow dendritic cells (BMDCs) [28] , unlike related TDMs and TMMs, GMMs and arabinose mycolates which activate BMDCs in terms of production of pro-inflammatory cytokines (IL-6 and TNF-α) and reactive oxygen species, upregulation of costimulatory molecules and activation of NLRP3 inflammasome by a mechanism dependent on Mincle [29] . However, they do show strong and selective effects in the stimulation of CD1b-restricted GEM T cell responses, mirroring the effects of the corresponding free mycolic acids [30] .
M A N U C R I P T
A C C E P T E D ACCEPTED MANUSCRIPT [31] (90 mg, 0.06 mmol) and DMAP (10 mg, 0.08 mmol) were added to a stirred solution of (S)-(2,2-dimethyl-1,3dioxolan-4-yl)methanol [32] (10 mg, 0.07 mmol) in CH 2 Cl 2 (2 mL). A solution of DCC (20 mg; 0.09 mmol) in CH 2 Cl 2 (2 mL) was added dropwise with stirring under nitrogen over 120 min then stirred for 1 h at room temperature. Precipitated dicyclohexyl urea was filtered off and washed with dichloromethane (10 mL). The solvent was evaporated and the crude product was purified by column chromatography eluting with petrol/ethyl acetate (20:1) to give a semi-solid, compound 9a (70 mg, 72%), ሾ ߙሿ ଶସ − 6. 10 mL) and the combined organic layers were dried and evaporated. The crude product was purified by column chromatography eluting with chloroform/methanol ((17S,18S) 
(R)-2,3-Dihydroxypropyl (2R)-2-((1R)-1-hydroxy-16-((1R,2S)-2-(20-methyl-19-oxooctatriacontyl)cyclopropyl)hexadecyl)tetracosanoate (10d)
(a) Dry cesium hydrogen carbonate (110 mg, 0.50 mmol) was added to a stirred solution of acid (11d) [36] (80 mg, 0.06 mmol) in a mixture of THF:DMF (1:1, 3 mL) at room temperature. The mixture was stirred for 1 h then R-tosylate (2) (40 mg, 0.13 mmol) was added .The mixture was brought to 70 °C and left at this temperature for 18 h, then worked up and purified as before to give a semi-solid, compound (12d) (64 mg, 85%), ሾ ߙሿ ଶସ − 8. 
M A N U C R I P T
A C C E P T E D ACCEPTED MANUSCRIPT 
(S)-2,3-Bis(benzyloxy)propyl alkanoate (15): General procedure
Cesium hydrogen carbonate was added to a stirred solution of 1-O-p-toluene-sulfonyl-(S)-2,3-di-O-benzylglycerol (14) [37] , and acid in dry DMF:THF (1:5, 2 mL) at room temperature. The mixture was stirred at 70 ºC for 2 days, then diluted with ethyl acetate (10 mL) and water (10 mL). The organic layer was separated and the aqueous layer was reextracted with ethyl acetate (3×10 mL). The combined organic layers were washed successively with water (15 mL) and brine (15 mL), dried and evaporated. The residue was purified by column chromatography.
(S)-2,3-Dihydroxypropyl alkanoate (16): General procedure
Palladium hydroxide on activated charcoal (20% Pd, 0.15 fold by weight) was stirred with compounds (15) in dry CH 2 Cl 2 : MeOH (1:1, 2 mL) at room temperature under hydrogen. The mixture was stirred for 24 h then filtered through celite. The celite was washed with CH 2 Cl 2 (10 mL), the filtrate was evaporated, and the residue purified by column chromatography.
(S)-2,3-Dihydroxypropyl (2R)-2-(1-hydroxy-12-((1R,2S)-2-(14-((2S)-2-eicosylcyclopropyl)tetradecyl)cyclopropyl)dodecyl)hexacosanoate (16b)

M A N U C R I P T
A C C E P T E D ACCEPTED MANUSCRIPT 2-((R)-1-hydroxy-18-((1R,2S)-2-((17S,18S) -17-methoxy-18-methylhexatriacontyl)cyclopropyl)octadecyl)tetracosanoate (16c) (a) Cesium hydrogen carbonate (0.0436 g, 0.225 mmol), tosylate (14) (0.0211 g, 0.0495 mmol) and acid 11c (0.0552 g, 0.0450 mmol) [36] gave a thick colourless oil which was purified by column chromatography (hexane/ethyl acetate, 10:1) to afford compound (15c), 6, 52.4, 35.3, 35.0, 32.3, 31.8, 30.4, 30.1, 29.9, 29.8, 29.7, 29.6, 29.55, 29.5, 29.45, 29.4, 29.3, 28.6, 27.5, 27.4, 26.0, 25.3, 22.6, 15.7, 14.7, 14. 2-((1R)-1-hydroxy-16-((1R,2S) 
(S)-2,3-Dihydroxypropyl(R)-
(S)-2,3-dihydroxypropyl(2R)-
Highlights:
Nine examples of R-and S-glycerol mycolates (GroMMs) based on synthetic mycolic acids matching the overall structures of alpha-, keto-and methoxymycolic acids of Mycobacterium tuberculosis and other mycobacteria.
